CRP and anemia (phenotype): Predictors of VTE after MPMs were female gender, history of VTE prior to MPMs diagnosis, metastatic first primary malignancy, poor performance status, anemia, elevated CRP level at MPMs diagnosis, ICU admission after MPMs diagnosis, chemotherapy, and referral to palliative care.